H40.249 Residual stage of angle-closure glaucoma, unspecified eye

Name of the Condition

• Residual Stage of Angle-Closure Glaucoma, Unspecified Eye

Summary

Residual stage of angle-closure glaucoma, unspecified eye, refers to the phase following an acute or chronic angle-closure event where the drainage angle remains partially or fully closed, but intraocular pressure may be controlled or stable. This stage indicates persistent anatomical changes or scarring from prior angle closure, with a risk of ongoing optic nerve damage if not monitored. Vision loss may be irreversible, and regular follow-up is essential to prevent progression.

Causes

The residual stage typically results from prior angle-closure episodes, where anatomical changes (e.g., peripheral anterior synechiae, iris bombe) or scarring prevent full reopening of the drainage angle. Contributing factors include incomplete treatment of acute episodes, chronic angle narrowing, or delayed intervention leading to permanent structural alterations.

Risk Factors

• History of acute or chronic angle-closure glaucoma.
• Persistent anatomical narrowing of the drainage angle.
• Peripheral anterior synechiae (adhesions) from prior inflammation.
• Inadequate or delayed treatment of prior angle-closure events.
• Age-related lens thickening or other structural eye changes.

Symptoms

• Persistent or intermittent elevated intraocular pressure.
• Gradual or stable vision loss (often irreversible).
• Residual optic nerve damage or visual field defects.
• Possible corneal changes from prior pressure spikes.

Diagnosis

Diagnosis involves a comprehensive eye exam, including tonometry to measure intraocular pressure, gonioscopy to assess the drainage angle, and optic nerve evaluation (e.g., ophthalmoscopy or imaging). Visual field testing may reveal residual defects. History of prior angle-closure events and response to treatment are also considered.

Treatment Options

• Monitoring intraocular pressure and optic nerve status.
• Topical or systemic medications to control pressure.
• Laser or surgical interventions (e.g., iridotomy, trabeculoplasty) if needed.
• Regular follow-up to adjust treatment and prevent progression.

Prognosis and Follow-Up

Prognosis depends on the extent of optic nerve damage and pressure control. Regular follow-up (every 3–6 months or as directed) is critical to monitor for progression. Vision loss may be irreversible, but timely management can slow further damage.

Complications

• Progressive optic nerve damage leading to vision loss.
• Recurrent angle-closure episodes.
• Corneal decompensation or scarring.
• Secondary glaucoma or cataract formation.

Lifestyle & Prevention

• Avoid activities that increase intraocular pressure (e.g., heavy lifting, certain medications).
• Manage systemic conditions (e.g., hypertension) that may affect eye health.
• Adhere to prescribed treatments and follow-up appointments.
• Protect eyes from injury or strain.

When to Seek Professional Help

Seek immediate care for sudden eye pain, blurred vision, halos around lights, or severe headache, as these may indicate acute angle-closure. Regular check-ups are essential for ongoing monitoring.

Tips for Medical Coders

Use H40.249 for the residual stage of angle-closure glaucoma when the eye is unspecified. Document the absence of laterality (right/left) and confirm the residual nature of the condition, including prior angle-closure history and current management. Ensure clinical notes support the diagnosis and stage.